These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9172288)

  • 1. A new modification of the APC resistance test.
    Vinazzer H
    Thromb Res; 1997 Apr; 86(1):69-72. PubMed ID: 9172288
    [No Abstract]   [Full Text] [Related]  

  • 2. A method for testing APC resistance in thrombophilic patients.
    Sochynsky CL; Joyner A; Ortel TI
    Am Clin Lab; 1994 Jul; 13(7):26-7. PubMed ID: 10147384
    [No Abstract]   [Full Text] [Related]  

  • 3. APC-resistance as measured by a Textarin time assay: comparison to the APTT-based method.
    Hoagland LE; Triplett DA; Peng F; Barna L
    Thromb Res; 1996 Sep; 83(5):363-73. PubMed ID: 8873345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protac, a commercially available protein C activator from the venom of Agkistrodon contortrix contortrix, can activate factor V and factor VIII.
    Gable PS; Le DT; Rapaport SI
    Thromb Res; 1997 Apr; 86(1):79-84. PubMed ID: 9172290
    [No Abstract]   [Full Text] [Related]  

  • 5. Activated protein C resistance assay performance: improvement by sample dilution with factor V-deficient plasma.
    Strobl FJ; Hoffman S; Huber S; Williams EC; Voelkerding KV
    Arch Pathol Lab Med; 1998 May; 122(5):430-3. PubMed ID: 9593344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on phospholipid antibodies, APC-resistance and associated mutation in the coagulation factor V gene.
    Bokarewa MI; Bremme K; Falk G; Sten-Linder M; Egberg N; Blombäck M
    Thromb Res; 1995 May; 78(3):193-200. PubMed ID: 7631299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter evaluation of a kit for activated protein C resistance on various coagulation instruments using plasmas from healthy individuals. The APC Resistance Study Group.
    Rosén S; Johansson K; Lindberg K; Dahlbäck B
    Thromb Haemost; 1994 Aug; 72(2):255-60. PubMed ID: 7831662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma resistance to activated protein C in venous and arterial thrombosis.
    Cushman M; Bhushan F; Bovill E; Tracy R
    Thromb Haemost; 1994 Oct; 72(4):647. PubMed ID: 7878648
    [No Abstract]   [Full Text] [Related]  

  • 9. Laboratory diagnosis of resistance to activated protein C (APC-resistance).
    Bertina RM
    Thromb Haemost; 1997 Jul; 78(1):478-82. PubMed ID: 9198200
    [No Abstract]   [Full Text] [Related]  

  • 10. High sensitivity and specificity of a coagulation assay for the detection of heterozygous and homozygous factor V Leiden--based resistance to activated protein C.
    Riewald M; Hintz G; Ritter M; Schmidt M; Neubauer A; Riess H
    Blood; 1996 Dec; 88(11):4398-9. PubMed ID: 8943880
    [No Abstract]   [Full Text] [Related]  

  • 11. Sensitivity and specificity of the APC resistance assay in detection of individuals with factor V(Leiden).
    Amin HM; Zeller JA; Shen T; Nassar A
    Am J Clin Pathol; 1997 Jun; 107(6):713-5. PubMed ID: 9169671
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of Hereditary Thrombophilia: Performance of Protein C (PC) Testing.
    Marlar RA; Gausman JN
    Methods Mol Biol; 2017; 1646():145-151. PubMed ID: 28804825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay.
    Wilmer M; Stocker C; Bühler B; Conell B; Calatzis A
    Am J Clin Pathol; 2004 Dec; 122(6):836-42. PubMed ID: 15539375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical application of a new specific functional assay to detect the factor V(Leiden) mutation associated with activated protein C resistance.
    van Oerle R; van Pampus L; Tans G; Rosing J; Hamulyák K
    Am J Clin Pathol; 1997 May; 107(5):521-6. PubMed ID: 9128263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of lupus anticoagulant on a commercially available kit for APC-resistance.
    Halbmayer WM; Haushofer A; Schön R; Fischer M
    Thromb Haemost; 1994 Oct; 72(4):645-6. PubMed ID: 7878647
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V; Leone G
    Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False positive activated protein C resistance test due to anti-phospholipid antibodies is corrected by platelet extract.
    Martorell JR; Muñoz-Castillo A; Gil JL
    Thromb Haemost; 1995 Aug; 74(2):796-7. PubMed ID: 8585026
    [No Abstract]   [Full Text] [Related]  

  • 18. Significant influence of the instrument on the result of the ProC Global assay. A multicenter evaluation using lyophilized plasmas and frozen plasma samples from carriers and non-carriers of the factor V Leiden mutation.
    Toulon P; Lequerrec A; Piquet P; Robert A; Biron C
    Thromb Res; 2002 Aug; 107(3-4):181-8. PubMed ID: 12431487
    [No Abstract]   [Full Text] [Related]  

  • 19. Inherited resistance to activated protein C, a major basis of venous thrombosis, is caused by deficient anticoagulant cofactor function of factor V.
    Dahlbäck B
    Haematologica; 1995; 80(2 Suppl):102-13. PubMed ID: 7628762
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a global screening assay for the investigation of the protein C anticoagulant pathway.
    Rimmer JE; Cooper PC; Brookfield CJ; Preston FE; Makris M
    Clin Lab Haematol; 2000 Dec; 22(6):351-4. PubMed ID: 11318801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.